Drugs & Targets FDA Grants Approvals to Tecentriq, Opdivo, Imbruvica, Lenvima June 02, 2016Vol.- No.-
Cancers Originating on Left Side of Colon Associated with Longer Survival, Study Says June 02, 2016Vol.- No.-
Researchers: Radiation After Surgery Benefits Older Patients More than Younger Patients May 02, 2016Vol.- No.-
Phase III Farletuzumab Trial Fails to Meet Endpoints in Platinum-Sensitive Disease May 02, 2016Vol.- No.-
